Magellan Biomedical Inc.
Magellan Biomedical is a spinoff from the Sunnybrook Research Institute, Toronto, Canada. The company is developing a platform technology for minimally invasive cardiovascular procedures. The company is working on a catheter steering and tracking technology that allows for localized, accurate, & reliable control of the device relative to the anatomy, while improving visualization and pushability without changing the conventional procedure flow. Magellan Biomedical’s technological developments promise significant improvements for various cardiovascular interventions and other minimally invasive procedures.